• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fulcrum Therapeutics, Inc. - Common Stock (NQ:FULC)

    5.370 -0.040 (-0.74%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 537,284
    Open 5.420
    Bid (Size) 5.240 (1)
    Ask (Size) 5.850 (1)
    Prev. Close 5.410
    Today's Range 5.280 - 5.698
    52wk Range 2.315 - 10.13
    Shares Outstanding 61,758,994
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics to Participate in Upcoming May Conferences
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +11.0%
    +11.0%
    1 Month
    +86.5%
    +86.5%
    3 Month
    +45.5%
    +45.5%
    6 Month
    +53.9%
    +53.9%
    1 Year
    -28.4%
    -28.4%

    More News

    Read More
    Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Scheduled For May 1, 2025
    Via Benzinga
    Earnings Scheduled For February 25, 2025
    Via Benzinga
    Expert Ratings For Fulcrum Therapeutics
    Via Benzinga
    Earnings Scheduled For November 13, 2024
    Via Benzinga
    Earnings Preview: Fulcrum Therapeutics
    Via Benzinga
    Uncovering Potential: Fulcrum Therapeutics's Earnings Preview
    Via Benzinga
    Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Which stocks are moving before the opening bell on Tuesday?
    Via Chartmill
    Fulcrum Therapeutics's Earnings Outlook
    Via Benzinga
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Bristol Myers Acquired MyoKardia Drops Fulcrum Agreement, Ending Cardiomyopathy Research Deal
    Via Benzinga
    Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    These stocks are moving in today's pre-market session
    Via Chartmill
    Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics to Participate in Upcoming December Conferences
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
    Via Investor's Business Daily

    Frequently Asked Questions

    Is Fulcrum Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Fulcrum Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Fulcrum Therapeutics, Inc. - Common Stock trade on?
    Fulcrum Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Fulcrum Therapeutics, Inc. - Common Stock?
    The ticker symbol for Fulcrum Therapeutics, Inc. - Common Stock is FULC on the Nasdaq Stock Market
    What is the current price of Fulcrum Therapeutics, Inc. - Common Stock?
    The current price of Fulcrum Therapeutics, Inc. - Common Stock is 5.370
    When was Fulcrum Therapeutics, Inc. - Common Stock last traded?
    The last trade of Fulcrum Therapeutics, Inc. - Common Stock was at 05/09/25 04:00 PM ET
    What is the market capitalization of Fulcrum Therapeutics, Inc. - Common Stock?
    The market capitalization of Fulcrum Therapeutics, Inc. - Common Stock is 331.65M
    How many shares of Fulcrum Therapeutics, Inc. - Common Stock are outstanding?
    Fulcrum Therapeutics, Inc. - Common Stock has 332M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.